Towa Pharmaceutical Co., Ltd. (TYO:4553)

Towa Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	140,445	131,879	142,933	93,275	135,736	120,231
Market Cap Growth	-5.83%	-7.73%	53.24%	-31.28%	12.90%	7.78%
Enterprise Value	325,401	326,106	308,406	222,967	195,152	187,298
Last Close Price	2853.00	2643.28	2797.20	1788.33	2516.48	2193.27
PE Ratio	8.78	6.95	8.84	42.38	8.53	8.61
Forward PE	8.03	8.37	11.99	11.96	8.06	10.11
PS Ratio	0.54	0.51	0.63	0.45	0.82	0.78
PB Ratio	0.81	0.77	0.92	0.68	1.03	1.03
P/TBV Ratio	1.10	1.05	1.36	1.11	1.74	1.18
P/FCF Ratio	42.42	-	-	-	12.35	41.88
P/OCF Ratio	3.99	5.64	17.41	36.67	6.13	10.01
EV/Sales Ratio	1.24	1.26	1.35	1.07	1.18	1.21
EV/EBITDA Ratio	7.50	7.52	8.68	8.95	6.62	6.17
EV/EBIT Ratio	14.29	14.03	17.48	40.43	10.53	9.40
EV/FCF Ratio	98.28	-	-	-	17.76	65.24
Debt / Equity Ratio	1.38	1.38	1.32	1.26	1.09	0.73
Debt / EBITDA Ratio	-	5.45	5.80	6.94	4.89	2.79
Debt / FCF Ratio	71.85	-	-	-	13.12	29.53
Asset Turnover	-	0.58	0.57	0.60	0.57	0.65
Inventory Turnover	-	1.58	1.51	1.64	1.43	1.61
Quick Ratio	1.36	1.33	1.26	1.00	0.73	1.33
Current Ratio	2.82	2.81	2.72	2.33	1.45	2.67
Return on Equity (ROE)	-	11.59%	11.05%	1.64%	12.79%	12.62%
Return on Assets (ROA)	-	3.22%	2.75%	0.98%	4.03%	5.26%
Return on Capital (ROIC)	-	3.77%	3.28%	1.18%	4.85%	6.41%
Return on Capital Employed (ROCE)	5.90%	6.10%	5.00%	1.90%	8.60%	10.30%
Earnings Yield	11.40%	14.40%	11.31%	2.36%	11.72%	11.61%
FCF Yield	2.36%	-4.04%	-20.74%	-28.07%	8.10%	2.39%
Dividend Yield	2.73%	2.65%	2.15%	3.36%	2.27%	2.01%
Payout Ratio	-	15.55%	18.25%	140.84%	15.15%	15.52%
Buyback Yield / Dilution	-0.01%	-0.01%	0.00%	2.19%	1.86%	3.57%
Total Shareholder Return	2.76%	2.64%	2.15%	5.55%	4.12%	5.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.